BackImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Other Assets

Track ImmunoPrecise Antibodies's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

ImmunoPrecise Antibodies Other Assets History

Loading

ImmunoPrecise Antibodies vs. peers: Other Assets Comparison

Loading

ImmunoPrecise Antibodies Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ImmunoPrecise Antibodies (IPA) FAQ

ImmunoPrecise Antibodies posts a other assets of $0 as of January 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, ImmunoPrecise Antibodies's other assets was $0. The latest reading is $0 (period ending January 2026). Use the history and growth charts on this page for a longer lookback.

Other Assets is one piece of ImmunoPrecise Antibodies's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IPA's other assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ImmunoPrecise Antibodies's other metric pages and overview cover the third.

Judging ImmunoPrecise Antibodies against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other assets easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.